Pilot Study to Determine if Working Memory Training Aids Cognitive Functioning in Patients With Parkinson's Disease (PDWM)
Parkinson Disease
About this trial
This is an interventional treatment trial for Parkinson Disease focused on measuring Parkinson Disease, near transfer, far transfer, working memory, fluid intelligence, cognitive training, dual n-back
Eligibility Criteria
Inclusion Criteria:
- clinical diagnosis of idiopathic Parkinson's disease
- self-reported concerns about their working memory, or working memory deficits that were identified by a clinical examination
- be classified as Hohn & Yahr Stage 1 or 2
- be receiving a stable dose of dopaminergic therapy
Exclusion Criteria:
- presence of dementia or other significant neurological or psychiatric conditions, as determined by clinical history
- Classification as Hohm & Yahr Stage 3 or 4
- Not on a stable dos of dopaminergic therapy
Sites / Locations
- Dalhousie University
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
Early training group
Late training group
No training group
The early training group will consist of 10 randomly assigned participants who will begin the adaptive working memory training task immediately after baseline assessment. They will continue training on the adaptive working memory training task for 5 weeks, after which they will continue for 5 weeks using a non-adaptive working memory task (active control task).
The late training group will consist of 10 randomly assigned participants who will engage in a non-adaptive working memory training task (i.e. an active control task) immediately after baseline assessment for 5 weeks. After the initial 5 weeks of the active control task they will then switch to the adaptive working memory task (the intervention) for 5 weeks. This is a randomized controlled cross-over design.
The no training group will engage in no training over the course of the pilot study, but will still participate in baseline, 5 week, 10 . This will allow us to determine if changes in the outcome and assessment variables are due to the working memory training or progression in the disease itself.